pharmaphorum May 13, 2022
Dominic Tyer

The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train an age of digital transformation.

In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus on one company and its view on pharma’s digital commercial strategy.

After an initial, and very necessary, frenetic response to the global pandemic, changes within pharma’s commercial organisations have yet to entirely settle, but there are many signs of new and future directions.

One of the firms setting out its vision for our digital future is Pfizer. Its chief digital and technology officer Lidia Fonseca...

Today's Sponsors

Canton & Company
Curation Health

Today's Sponsors

Oliver Wyman

Today's Sponsor

Canton & Company

Topics: Digital Health, Pharma, Pharma / Biotech, Technology
Study: Many digital health startups lack clinical trials, regulatory filings
Closing the digital expectation gap in pharma
Patients Are Ready for a Digital Future, Here’s Pharma’s Path Toward the Next Growth Horizon
Survey: Pharma bullish on digital innovation, but failing on execution
Clinical Trial Focuses on Remote Monitoring of Cancer Patients